Assessment and Implication of the Allergic Sensitivity to a Single Dose of Recombinant Human Hyaluronidase Injection: A Double-blind, Placebo-controlled Clinical Trial
The DOI matches its Crossref record.
Abstract
Animal-extracted injectable hyaluronidases have been used safely for more than 50 years to increase the dispersion and absorption of coadministered drugs and fluids; however, concern still exists about the allergic and immunological risks of these products. Hylenex recombinant, a novel formulation of recombinant human hyaluronidase, has been developed as an alternative to these animal-derived hyaluronidases. Because recombinant human hyaluronidase is a human (nonforeign) protein manufactured into a purer preparation than the animal extracts, it is expected to convey reduced allergic and immunologic risks. The recombinant human hyaluronidase product was well tolerated in this double-blind, placebo-controlled, single-dose study. No allergic reactions were observed among the 100 volunteer subjects who were injected intradermally. These findings supported the US Food and Drug Administration approval of the recombinant human hyaluronidase product.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Peripheral Difficult Venous Access in Children
Rauch, D., Dowd, D., Eldridge, D., Mace, S., Schears, G., & Yen, K. (2009) · Clinical Pediatrics · doi:10.1177/0009922809335737 · Cited by 80
Wasserman, R. L. (2017) · Immunotherapy · doi:10.2217/imt-2017-0092 · Cited by 77
Difficult peripheral venous access: recognizing and managing the patient at risk
Walsh, G. (2008) · Journal of the Association for Vascular Access · doi:10.2309/java.13-4-7 · Cited by 58
Wasserman, R. L., Melamed, I., Stein, M. R., Engl, W., Sharkhawy, M., Leibl, H., Puck, J., Rubinstein, A., Kobrynski, L., Gupta, S., et al. (2016) · Journal of Clinical Immunology · doi:10.1007/s10875-016-0298-x · Cited by 52
A Systematic Data Review of the Cost of Rehydration Therapy
Pershad, J. (2010) · Applied Health Economics and Health Policy · doi:10.2165/11534500-000000000-00000 · Cited by 15
Metadata
- Authors
- Yocum, R. C., Kennard, D., & Heiner, L. S.
- Venue
- Journal of Infusion Nursing
- Published
- 2007-09
- Volume
- 30
- Issue
- 5
- Pages
- 293-299
- ISSN
- 1533-1458 (ISSN-L)
- OpenAlex
- W2052968125
- Cited by
- 74
- References
- 0
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessment and Implication of the Allergic Sensitivity to a Single Dose of Recombinant Human Hyaluronidase Injection: A Double-blind, Placebo-controlled Clinical Trial. https://app.cochat.ai/papers/10.1097/01.nan.0000292572.70387.17
- The paper
- Yocum, R. C., Kennard, D., & Heiner, L. S. (2007). Assessment and Implication of the Allergic Sensitivity to a Single Dose of Recombinant Human Hyaluronidase Injection: A Double-blind, Placebo-controlled Clinical Trial. Journal of Infusion Nursing. https://doi.org/10.1097/01.nan.0000292572.70387.17
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.